Protein–protein interactions (PPIs) and protein–metabolite
interactions play a key role in many biochemical processes, yet they
are often viewed as being independent. However, the fact that small
molecule drugs have been successful in inhibiting PPIs suggests a
deeper relationship between protein pockets that bind small molecules
and PPIs. We demonstrate that 2/3 of PPI interfaces, including antibody–epitope
interfaces, contain at least one significant small molecule ligand
binding pocket. In a representative library of 50 distinct protein–protein
interactions involving hundreds of mutations, >75% of hot spot
residues
overlap with small molecule ligand binding pockets. Hence, ligand
binding pockets play an essential role in PPIs. In representative
cases, evolutionary unrelated monomers that are involved in different
multimeric interactions yet share the same pocket are predicted to
bind the same metabolites/drugs; these results are confirmed by examples
in the PDB. Thus, the binding of a metabolite can shift the equilibrium
between monomers and multimers. This implicit coupling of PPI equilibria,
termed “metabolic entanglement”, was successfully employed
to suggest novel functional relationships among protein multimers
that do not directly interact. Thus, the current work provides an
approach to unify metabolomics and protein interactomics.